Although Amgen (currently trading at $299.86 per share) has gained 9.6% over the last six months, it has trailed the S&P ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

In the closing of the recent trading day, Amgen (AMGN) stood at $297.32, denoting a +1.18% move from the preceding trading day.

Amgen is scheduled to report its third-quarter earnings next month, and analysts forecast a modest single-digit decline in ...

Amgen Inc. (NASDAQ:AMGN) is included among the 11 Cheap Quarterly Dividend Stocks to Buy Right Now. Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, offers investors a strong and diverse ...

Amgen Inc. (NASDAQ:AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Amgen Inc.’s (NASDAQ:AMGN) and AstraZeneca’s Tezspire received a positive ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

When it comes to tracking investment disclosures, Congresswoman Marjorie Taylor Greene (R-Ga.) and Ark Funds founder Cathie ...

Martin Capital sold 12,035 JPMorgan shares worth an estimated $3.6 million in the third quarter. The transaction value represented approximately 1.4% of the firm's reportable assets under management ...